Tempest Therapeutics Inc
Change company Symbol lookup
Select an option...
TPST Tempest Therapeutics Inc
PETV PetVivo Holdings Inc
KMI Kinder Morgan Inc
NXPL NextPlat Corp
D Dominion Energy Inc
CVS CVS Health Corp
CVI CVR Energy Inc
CTRE CareTrust REIT Inc
CSWC Capital Southwest Corp
CSCO Cisco Systems Inc

Health Care : Biotechnology |
Company profile

Tempest Therapeutics, Inc. (Tempest) is a clinical-stage oncology company. The Company is focused on developing small molecules that combine both tumor-targeted and immune-mediated mechanisms with the potential to treat a range of tumors. The Company’s two clinical programs include TPST-1120 and TPST-1495. TPST-1120 is a selective antagonist of peroxisome proliferator-activated receptor alpha (PPARa). TPST-1120 is in Phase I and II trials in solid tumors, including a global randomized Phase Ib/II trial in combination with the standard-of-care first-line regimen of atezolizumab and bevacizumab in patients with advanced or metastatic hepatocellular carcinoma (HCC). Its second clinical program, TPST-1495, a dual antagonist of the EP2 and EP4 receptors of prostaglandin E2, and is in Phase I monotherapy and combination trials in solid tumors.

Closing Price
Day's Change
-0.20 (-9.76%)
B/A Size
Day's High
Day's Low
(Heavy Day)

10-day average volume:

Warner Bros. Discovery wants to exit regional TV sports: WSJ

5:29 pm ET February 24, 2023 (MarketWatch)

Warner Bros. Discovery Inc. (WBD) wants to stop running the business that oversees three regional sports TV channels that air games for professional teams in Colorado and Utah, as well as Pittsburgh and Houston, the Wall Street Journal reported on Friday. The Journal said an executive from that business told the sports teams that bankruptcy was an option for the business, and that "the business will not have sufficient cash to pay the upcoming rights fees," and that Warner Bros. Discovery "will not fund our shortfalls." "Unless we can reach a deal to transfer ownership of the network (and the attendant rights)" by March 31, "our only realistic option is to file for chapter 7 liquidation," the letter said, according to the Journal. "We find ourselves running out of time and options." The Journal said the letter proposed that the channels, which operate under the AT&T SportsNet brand name, "transfer ownership of the networks and programming rights to the teams for no purchase price consideration beyond a release by the teams of any future claims against the networks." Shares of Warner Bros. Discovery finished 1.1% lower on Friday.

-Bill Peters


(END) Dow Jones Newswires

February 24, 2023 17:29 ET (22:29 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.